RecruitingNCT05969951

VTE Risk Prevention System Based on Big Data Analysis and Multimodule System

Construction of Perioperative Venous Thromboembolism Risk Prevention System Based on Big Data Analysis and Multimodule System


Sponsor

Shengjing Hospital

Enrollment

100,000 participants

Start Date

Apr 14, 2021

Study Type

OBSERVATIONAL

Conditions

Summary

Venous thromboembolism (VTE) is one of the most common complications in perioperative period and the most common cause of postoperative death. VTE includes deep vein thrombosis (DVT) and acute pulmonary thromboembolism (PTE). Since the embolus of PTE comes from the deep vein thrombosis, and not all PE patients can present obvious clinical symptoms, VTE is currently considered as a disease for research, prevention, diagnosis and treatment at home and abroad. Therefore, we urgently need to develop a more comprehensive and reliable perioperative VTE risk prevention system based on medical big data and multi-module computer in current clinical practice, so as to effectively guide the prevention of DVT/PE, and thus reduce the perioperative mortality.


Eligibility

Min Age: 10 YearsMax Age: 90 Years

Inclusion Criteria3

  • perioperative patients;
  • Age range from 10 to 90 years old, gender unlimited;
  • Sign informed consent.

Exclusion Criteria1

  • (1) non-operative patients; (2) have developed deep vein thrombosis and/or pulmonary embolism before surgery; (3) emergency operation patients; (4) Patients considered unsuitable for inclusion in the study.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Shengjing Hospital of China Medical University

Shenyang, Liaoning, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05969951


Related Trials